Results of IVGTT, hyperinsulinemic-euglycemic clamp, and indirect calorimetry in male study participants before and after bed rest
. | Before bed rest . | After bed rest . | ||
---|---|---|---|---|
FDR group . | CON group . | FDR group . | CON group . | |
n | 13 | 20 | 13 | 20 |
Fasting plasma glucose (mmol/l) | ||||
Basal | 4.8 ± 0.4 | 4.6 ± 0.4 | 4.8 ± 0.3 | 4.6 ± 0.4 |
Insulin-stimulated state | 5.2 ± 0.4 | 5.2 ± 0.3 | 5.2 ± 0.3 | 5.1 ± 0.3 |
Fasting plasma insulin (pmol/l)* | ||||
Basal | 32 ± 10 | 28 ± 10 | 51 ± 22† | 37 ± 18† |
Insulin-stimulated state | 777 ± 126 | 769 ± 176 | 833 ± 160 | 832 ± 160 |
Fasting plasma C-peptide (pmol/l) | ||||
Basal | 522 ± 117 | 376 ± 168‡ | 678 ± 201† | 472 ± 187†§ |
Insulin-stimulated state | 495 ± 156 | 323 ± 182‡ | 641 ± 238† | 412 ± 212†§ |
Fasting plasma glycerol (μmol/l)* | ||||
Basal | 65 ± 17 | 89 ± 35‡ | 67 ± 18 | 65 ± 28† |
Insulin-stimulated state | 26 ± 8 | 27 ± 16 | 28 ± 11 | 27 ± 10 |
Fasting plasma lactate (mmol/l)* | ||||
Basal | 0.6 ± 0.1 | 0.7 ± 0.3 | 0.8 ± 0.3† | 0.7 ± 0.2 |
Insulin-stimulated state | 1.1 ± 0.2 | 1.2 ± 0.4 | 1.0 ± 0.4 | 1.1 ± 0.2† |
Fasting plasma free fatty acids (μmol/l) | ||||
Basal | 366 ± 76 | 461 ± 227 | 283 ± 128 | 258 ± 131† |
Insulin-stimulated state | 10.8 ± 6.5 | 8.8 ± 4.2 | 11.5 ± 5.6 | 9.2 ± 4.5 |
M value (mg · min−1 · kg body wt−1) | ||||
Insulin-stimulated state | 9.9 ± 2.0 | 11.3 ± 1.5‡ | 8.0 ± 2.2† | 8.4 ± 1.7† |
M value (mg · min−1 · FFM−1) | ||||
Insulin-stimulated state | 13.9 ± 2.1 | 14.4 ± 1.7 | 11.1 ± 2.5† | 10.7 ± 2.0† |
Glucose oxidation rate (mg · min−1 · FFM−1) | ||||
Basal | 1.8 ± 0.4 | 1.6 ± 0.5 | 2.5 ± 0.7† | 2.5 ± 0.9† |
Insulin-stimulated state | 4.7 ± 0.7 | 4.5 ± 0.6 | 4.5 ± 0.7 | 4.3 ± 0.7 |
Fat oxidation rate (mg · min−1 · FFM−1) | ||||
Basal | 0.9 ± 0.2 | 1.0 ± 0.3 | 0.6 ± 0.3† | 0.6 ± 0.4† |
Insulin-stimulated state | 0.01 ± 0.24 | 0.05 ± 0.28 | -0.03 ± 0.28 | 0.05 ± 0.26 |
Nonoxidative glucose metabolism (mg · min−1 · FFM−1) | ||||
Insulin-stimulated state | 9.2 ± 1.8 | 9.9 ± 1.7 | 6.6 ± 2.3† | 6.5 ± 2.0† |
Respiration quotient | 0.83 ± 0.02 | 0.82 ± 0.03 | 0.87 ± 0.04† | 0.86 ± 0.05† |
Basal | ||||
Insulin-stimulated state | 0.96 ± 0.03 | 0.95 ± 0.03 | 0.96 ± 0.04 | 0.95 ± 0.03 |
FPIR (pmol · l−1 · min−1)* | 2,173 ± 1,704 | 1,866 ± 932 | 3,368 ± 4,047† | 3,023 ± 1,702† |
AUC10min (pmol · l−1 · min−1) | 2,440 ± 1,734 | 2,132 ± 967 | 3,766 ± 4,134† | 3,355 ± 1,765† |
PHI1* | 18.0 ± 12.7 | 17.2 ± 7.2 | 27.6 ± 24.2† | 27.3 ± 13.5† |
. | Before bed rest . | After bed rest . | ||
---|---|---|---|---|
FDR group . | CON group . | FDR group . | CON group . | |
n | 13 | 20 | 13 | 20 |
Fasting plasma glucose (mmol/l) | ||||
Basal | 4.8 ± 0.4 | 4.6 ± 0.4 | 4.8 ± 0.3 | 4.6 ± 0.4 |
Insulin-stimulated state | 5.2 ± 0.4 | 5.2 ± 0.3 | 5.2 ± 0.3 | 5.1 ± 0.3 |
Fasting plasma insulin (pmol/l)* | ||||
Basal | 32 ± 10 | 28 ± 10 | 51 ± 22† | 37 ± 18† |
Insulin-stimulated state | 777 ± 126 | 769 ± 176 | 833 ± 160 | 832 ± 160 |
Fasting plasma C-peptide (pmol/l) | ||||
Basal | 522 ± 117 | 376 ± 168‡ | 678 ± 201† | 472 ± 187†§ |
Insulin-stimulated state | 495 ± 156 | 323 ± 182‡ | 641 ± 238† | 412 ± 212†§ |
Fasting plasma glycerol (μmol/l)* | ||||
Basal | 65 ± 17 | 89 ± 35‡ | 67 ± 18 | 65 ± 28† |
Insulin-stimulated state | 26 ± 8 | 27 ± 16 | 28 ± 11 | 27 ± 10 |
Fasting plasma lactate (mmol/l)* | ||||
Basal | 0.6 ± 0.1 | 0.7 ± 0.3 | 0.8 ± 0.3† | 0.7 ± 0.2 |
Insulin-stimulated state | 1.1 ± 0.2 | 1.2 ± 0.4 | 1.0 ± 0.4 | 1.1 ± 0.2† |
Fasting plasma free fatty acids (μmol/l) | ||||
Basal | 366 ± 76 | 461 ± 227 | 283 ± 128 | 258 ± 131† |
Insulin-stimulated state | 10.8 ± 6.5 | 8.8 ± 4.2 | 11.5 ± 5.6 | 9.2 ± 4.5 |
M value (mg · min−1 · kg body wt−1) | ||||
Insulin-stimulated state | 9.9 ± 2.0 | 11.3 ± 1.5‡ | 8.0 ± 2.2† | 8.4 ± 1.7† |
M value (mg · min−1 · FFM−1) | ||||
Insulin-stimulated state | 13.9 ± 2.1 | 14.4 ± 1.7 | 11.1 ± 2.5† | 10.7 ± 2.0† |
Glucose oxidation rate (mg · min−1 · FFM−1) | ||||
Basal | 1.8 ± 0.4 | 1.6 ± 0.5 | 2.5 ± 0.7† | 2.5 ± 0.9† |
Insulin-stimulated state | 4.7 ± 0.7 | 4.5 ± 0.6 | 4.5 ± 0.7 | 4.3 ± 0.7 |
Fat oxidation rate (mg · min−1 · FFM−1) | ||||
Basal | 0.9 ± 0.2 | 1.0 ± 0.3 | 0.6 ± 0.3† | 0.6 ± 0.4† |
Insulin-stimulated state | 0.01 ± 0.24 | 0.05 ± 0.28 | -0.03 ± 0.28 | 0.05 ± 0.26 |
Nonoxidative glucose metabolism (mg · min−1 · FFM−1) | ||||
Insulin-stimulated state | 9.2 ± 1.8 | 9.9 ± 1.7 | 6.6 ± 2.3† | 6.5 ± 2.0† |
Respiration quotient | 0.83 ± 0.02 | 0.82 ± 0.03 | 0.87 ± 0.04† | 0.86 ± 0.05† |
Basal | ||||
Insulin-stimulated state | 0.96 ± 0.03 | 0.95 ± 0.03 | 0.96 ± 0.04 | 0.95 ± 0.03 |
FPIR (pmol · l−1 · min−1)* | 2,173 ± 1,704 | 1,866 ± 932 | 3,368 ± 4,047† | 3,023 ± 1,702† |
AUC10min (pmol · l−1 · min−1) | 2,440 ± 1,734 | 2,132 ± 967 | 3,766 ± 4,134† | 3,355 ± 1,765† |
PHI1* | 18.0 ± 12.7 | 17.2 ± 7.2 | 27.6 ± 24.2† | 27.3 ± 13.5† |
Data are means ± SD. Respiration quotient = VCO2/Vo2; FPIR = incremental area; AUC10min = total area under the IVGTT curve in the first 10 min; PHI1 = AUCinsulin/AUCglucose.
*Log-transformed data.
†Significant difference before versus after bed rest; P < 0.05.
‡Significant difference between FDR and CON groups before bed rest, P < 0.05.
§Significant difference between FDR and CON groups after bed rest, P < 0.05.